AVAI BIO, INC.

Avai Bio, Inc.

Overview

• Company focus: Technology company that acquires, creates, and develops AI-based technologies and provides information technology consulting services.
• Positioning: Positions itself as a native expert in information technology based on artificial intelligence.
• Capabilities: Core acquisitions and partnerships provide full-stack software development, database management, data integration, project management, and cloud services.
• Name and ticker: Filed a name change to Avai Bio, Inc. on February 3, 2026; trading symbol remains AVAI on the OTC Markets.

Business activities

AI technology and software development

• Develops and deploys AI-based solutions, including unsupervised learning capabilities that feed supervised learning.
• Describes a self-sustained data preparation process (Unsupervised Clustering) that supports supervised models and enables what the company calls “True Learning from Experience.”
• Emphasizes cross-domain knowledge transfer to improve performance across different application areas.

Acquisitions and asset development

• Avant! AI assets acquired April 3, 2023, via Asset Purchase Agreement for 26,000,000 common shares.
• Instant Fame assets acquired April 3, 2023, via Treasure APA with issuance of 5,000 Series A Preferred shares.
• Joint venture/license arrangements with Ainnova Tech Inc. to provide resources for AI initiatives.
• Thy News LLC assets acquired June 28, 2019; platform aggregates news from thousands of sources.
• Wired4Health assets acquired April 5, 2024, via Secured Note and Series B Preferred Stock; the Wired4Health APA was later canceled on September 9, 2024.
• Elentina involvement: capital markets services arrangement with stock-based compensation.

Product platforms and offerings

• Avant-Ai: text-generation, deep-learning self-training system using unsupervised learning with cross-domain applicability.
• InstantFAME: digital rating and secured sales/digital auction platforms, including virtual reality platforms and open bid auctions as part of the acquired assets.
• Thy News: news aggregation app with customizable feeds; sources increased from about 24,000 at an early stage to 99,000 by the end of 2019 and 149,000 processed sources as of December 31, 2025.

Operational footprint

• No owned real estate; rents a virtual office in Las Vegas, Nevada, and maintains a registered office in Vilnius, Lithuania.

Financial snapshot

• Profitability and cash flow:
  • Net loss for the year ended March 31, 2026: $1,749,509.
  • Net loss for the year ended March 31, 2025: $1,142,115.
  • Funded to date through equity issuances and debt, including convertible debt.
  • Stockholders’ deficit as of March 31, 2026: $2,815,155.
  • Accumulated deficit as of March 31, 2026: $5,868,019.
• Capital needs and financing:
  • Management estimates needing approximately $10,000,000 to implement the business plan.
  • Future equity offerings could dilute existing shareholders; debt financing may include covenants that restrict activities.
  • Management believes favorable capital may be limited.
• Public market and liquidity:
  • Trades on the OTCQB market under ticker AVAI; public market for the security is limited and may experience price and liquidity volatility.
• Share count and trading status:
  • Outstanding common shares: 153,916,565 (reporting date).
  • Restricted shares: 38,562,563.
  • Freely tradable shares: 115,354,002.
• Dividends:
  • No cash dividends have been paid to date and there are no immediate plans to pay cash dividends.

Governance and controls

• Disclosure controls and procedures were previously reported as not effective due to resource constraints and reliance on outside consultants.
• Board and management:
  • Ivan Lunegov — President & Director
  • Natalija Tunevic — Secretary
  • Vitalis Racius — CFO, Director & Treasurer
  • Chris Winter — CEO (not a director)

Key operational and market risks

• Limited operating history in an evolving industry, with risks related to revenue forecasting, business expansion, and integration of acquisitions.
• Dependence on key personnel and the ability to attract and retain talent.
• Need for substantial capital to support growth and the risk of dilution from equity financings or restrictive covenants from debt financings.
• Public market risks associated with OTCQB status, including potential price and liquidity volatility and penny stock considerations.
• Cybersecurity and data privacy governance gaps and absence of a formal enterprise risk management program.

Notable corporate events (timeline)

• June 28, 2019: Acquisition of Thy News LLC.
• April 3, 2023: Asset purchases for Avant! AI assets (26,000,000 shares issued) and Instant Fame assets (5,000 Series A Preferred shares).
• 2023–2024: Elentina capital markets services arrangement; May 7, 2024 designation of 1,000,000 Series A Preferred shares.
• April 5, 2024: Asset Purchase Agreement for Wired4Health assets.
• September 9, 2024: Cancellation of the Wired4Health APA.
• February 3, 2026: Certificate of Amendment filed to rename the company to Avai Bio, Inc.; trading symbol remains AVAI.